Dr Reddys Laboratories Share Price Today - Live Blog for September 10, 2025

Dr Reddys Laboratories Ltd shares saw a decrease of -0.12%, reaching a current market price of ₹1,302.60. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.02%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,304.25 per share.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.06% recently. As of now, this stock is actively trading at a current market price of ₹1,302.65 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd share price has declined by -0.05%, and it's currently trading at ₹1,301.85. The stock maintains a PE of 19.0000, while the industry PE is 34.6998, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd experienced a -0.01% dip in its share price and is currently trading at ₹1,302.55. The stock has a PE ratio of 19.0000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.25% recently. As of now, this stock is actively trading at a current market price of ₹1,302.00 per share, attracting attention from investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.01% decline, and it currently trades at ₹1,298.50 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's stock price surged by 0.09%, reaching the current market value of ₹1,299.35 per share. This surge is a testament to the stock's recent performance.

The stock of Dr Reddys Laboratories Ltd is facing a -0.19% decline and is currently trading at ₹1,298.15 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd witnessed a -0.24% decrease in its share price, and it is currently trading at ₹1,301.10. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.0000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.06% drop, and it's now trading at ₹1,304.25 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's share price rallied by 0.04%, reaching the current market price of ₹1,305.05. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd share price surged by 0.09%. With its current market price standing at ₹1,303.00 per share, this stock is garnering increased attention from the investment community.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.09%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,303.00 per share.

Dr Reddys Laboratories Ltd's share price has fallen by -0.15%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,300.90, and market participants are assessing the implications. The stock has a PE ratio of 19.0000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a substantial 0.09% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,301.35, making it an appealing option for investors.

Dr Reddys Laboratories Ltd share price surged by 0.08%. With its current market price standing at ₹1,306.00 per share, this stock is garnering increased attention from the investment community.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.08% increase and currently trading at ₹1,306.00 per share. This upward trajectory is turning heads in the market.

The stock of Dr Reddys Laboratories Ltd suffered a -0.12% drop, and it's now trading at ₹1,305.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd witnessed a notable 0.13% surge in its share price and is presently trading at ₹1,306.90, captivating the attention of market participants.

After a -0.23% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,305.00. The stock has a PE ratio of 19.0000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's shares experienced a 0.28% uptick, and they are currently valued at ₹1,309.10, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd experienced a substantial 0.69% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,305.30, making it an appealing option for investors.

Dr Reddys Laboratories Ltd observed a -0.15% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,295.90. The stock has a PE ratio of 19.0000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.03% drop, and it's now trading at ₹1,296.55 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

After a -0.09% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,292.90. The stock has a PE ratio of 19.0000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.